HealthDrug That Can Prevent Migraine Without Significant Side Effects Shows Promise In Clinical Trial In a clinical trial involving more than 800 patients who frequently suffer from a migraine, galcanezumab reduced monthly migraine days by 4.7 days. The side effects are also very minimal that fewer than 5 percent of the participants quit the trial.by Allan Adamson
HealthInsys Sales Representative Admits Bribing Doctors To Prescribe Opioid Painkiller Subsysby Allan Adamson
HealthWhy A 32-Year-Old Dad Wanted To 'Cut Off His Leg' After A Brush With Common Hogweedby Steven Lerner
HealthPresident Trump Says Major Pharmaceutical Companies To Slash Drug Prices In Two Weeksby Allan Adamson
HealthNew Study Suggests That A Woman's Voice Becomes 'Deeper' After Giving Birth To Her First Childby Elyse Johnson
HealthAmerican Cancer Society Suggests Colon Cancer Screenings To Begin At Age 45 To Prevent Early Deathsby Elyse Johnson
HealthPlacenta Linked To Greater Risk Of Schizophrenia, ADHD, Autism, And Tourettes Syndromeby Athena Yenko